Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$306M |
| 2 |
Vanguard Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$251M |
| 4 |
Costco
COST
|
+$235M |
| 5 |
Lyft
LYFT
|
+$235M |
Top Sells
| 1 |
Ferguson
FERG
|
+$727M |
| 2 |
Linde
LIN
|
+$619M |
| 3 |
Medtronic
MDT
|
+$521M |
| 4 |
Goldman Sachs
GS
|
+$361M |
| 5 |
Microsoft
MSFT
|
+$321M |
Sector Composition
| 1 | Technology | 25.13% |
| 2 | Healthcare | 13.18% |
| 3 | Financials | 12.44% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Bolt Biotherapeutics
BOLT
$10.1M
| $721K | ﹤0.01% |
2,331
+727
| +45% | +$225K |
|
3527
SK Telecom
SKM
$8.37B
| $718K | ﹤0.01% |
13,864
+4,263
| +44% | +$221K |
|
3528
Wave Life Sciences
WVE
$1.14B
| $715K | ﹤0.01% |
107,433
-14,901
| -12% | -$99.2K |
|
3529
SSR Mining
SSRM
$4.62B
| $713K | ﹤0.01% |
45,736
-225,540
| -83% | -$3.52M |
|
|
INFI
3530
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $711K | ﹤0.01% |
237,735
+174,698
| +277% | +$522K |
|
3531
LifeVantage
LFVN
$149M
| $709K | ﹤0.01% |
96,518
-32,193
| -25% | -$236K |
|
3532
Ryvyl
RVYL
$9.47M
| $709K | ﹤0.01% |
+5,943
| New | +$709K |
|
3533
Clover Health Investments
CLOV
$1.61B
| $708K | ﹤0.01% |
53,176
+11,866
| +29% | +$158K |
|
|
ENTO
3534
Entero Therapeutics
ENTO
$3.65M
| $708K | ﹤0.01% |
7
+2
| +40% | +$202K |
|
3535
Oramed Pharmaceuticals
ORMP
$99.6M
| $707K | ﹤0.01% |
+52,904
| New | +$707K |
|
|
TAST
3536
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $705K | ﹤0.01% |
117,376
-2,181
| -2% | -$13.1K |
|
3537
LiveOne
LVO
$61.4M
| $703K | ﹤0.01% |
148,850
-22,317
| -13% | -$105K |
|
3538
Marqeta
MQ
$2.68B
| $703K | ﹤0.01% |
+25,046
| New | +$703K |
|
|
JNCE
3539
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $695K | ﹤0.01% |
102,268
+31,097
| +44% | +$211K |
|
|
HBMD
3540
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $695K | ﹤0.01% |
43,075
-128
| -0.3% | -$2.07K |
|
|
AFIB
3541
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $694K | ﹤0.01% |
40,913
-139,284
| -77% | -$2.36M |
|
3542
Cardiff Oncology
CRDF
$138M
| $693K | ﹤0.01% |
104,208
+89,859
| +626% | +$598K |
|
3543
First Northwest Bancorp
FNWB
$63.1M
| $693K | ﹤0.01% |
39,527
-22,755
| -37% | -$399K |
|
3544
Mayville Engineering Co
MEC
$295M
| $691K | ﹤0.01% |
34,337
+2,554
| +8% | +$51.4K |
|
3545
Fonar
FONR
$98.8M
| $690K | ﹤0.01% |
39,041
-16,794
| -30% | -$297K |
|
|
NGMS
3546
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $690K | ﹤0.01% |
11,234
-673
| -6% | -$41.3K |
|
|
ONCR
3547
DELISTED
Oncorus, Inc.
ONCR
| $690K | ﹤0.01% |
49,937
+32,192
| +181% | +$445K |
|
3548
4D Molecular Therapeutics
FDMT
$330M
| $689K | ﹤0.01% |
28,636
+8,219
| +40% | +$198K |
|
3549
Schwab US Large-Cap Growth ETF
SCHG
$49.3B
| $687K | ﹤0.01% |
37,616
+6,696
| +22% | +$122K |
|
|
PZN
3550
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $685K | ﹤0.01% |
62,240
+135
| +0.2% | +$1.49K |
|